You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

daratumumab

Showing 26 - 50 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Daratumumab / Hyaluronidase Injection
  • Chicago, Illinois
    Northwestern
Jun 17, 2022

Patient and Healthcare Provider Satisfaction of Daratumumab Use

Recruiting
  • Multiple Myeloma
  • +5 more
  • Daratumumab
  • Frankfurt, Hessen, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Aug 1, 2022

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)

Recruiting
  • Neuromyelitis Optica
  • +2 more
  • Daratumumab
  • Placebo
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 19, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (Daratumumab, Clarithromycin,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
Jun 8, 2022

High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

Completed
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 4, 2023

Multiple Myeloma Trial in Cologne (Daratumumab)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
Apr 4, 2022

AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
Aug 3, 2022

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Daratumumab in Combination With Bortezomib, Thalidomide, and

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
  • (no location specified)
Sep 27, 2022

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • daratumumab
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2022

Lupus Nephritis Trial in Rochester (Daratumumab)

Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 23, 2022

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 6, 2022

Selinexor, Daratumumab and Dexamethasone in Chinese Multiple

Not yet recruiting
  • Multiple Myeloma at First Relapse
    • (no location specified)
    Sep 27, 2022

    Hemolytic Anemia Trial in Lebanon (Daratumumab / Hyaluronidase Injection)

    Recruiting
    • Hemolytic Anemia
    • Daratumumab / Hyaluronidase Injection
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jun 15, 2022

    Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

    Recruiting
    • Multiple Myeloma
    • Daratumumab
    • +3 more
    • Hackensack, New Jersey
      John Theurer Cancer Center
    Jun 10, 2022

    Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

    Recruiting
    • Multiple Myeloma in Relapse
    • Daratumumab/Lenalidomide/Dexamethasone for 24 months
    • Daratumumab/Lenalidomide/Dexamethasone until progression
    • Paris, France
      Saint Antoine Hospital - Hematology Department
    Jun 10, 2022

    High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

    Not yet recruiting
    • High-Risk de Novo Multiple Myeloma
    • Daratumumab
    • +5 more
    • Badalona, Spain
    • +9 more
    Apr 27, 2023

    Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

    Recruiting
    • Newly Diagnosed Multiple Myeloma
    • Daratumumab
    • +4 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 29, 2022